Analysis of motor, cognitive, and depressive manifestations in Parkinson’s disease patients
DOI:
https://doi.org/10.34024/rnc.2008.v16.8657Keywords:
Parkinson Disease, Motor activity, v, DepressionAbstract
Introduction. Parkinson disease (PD) is a central nervous system neurodegenerative disorder primarily characterized by motor dysfunction but cognitive disorders, including dementia, can be present. Objective. The present study aimed at investigating the association among motor, cognitive, and depressive manifestations in Parkinson disease patients. Methods. Ten PD volunteers had been evaluated about their motor, cognitive, and emotional conditions. Results. We observed that 40% of the individuals presented only a minimum degree of motor dysfunctions, and that no one showed a maximum degree of incapacity. 30% of individuals showed cognitive dysfunctions that did not have significant correlation with the presence of motor dysfunctions. 70% of individuals presented depression independently of motor or cognitive dysfunction. Conclusion. In this study we did not observe association among motor or cognitive dysfunction and depression. Future studies with a greater sample are necessary to evaluate those associations.
Metrics
References
Kaplan HIS, Benjamin JG, Jack A. Compêndio de Psiquiatria: ciências do comportamento e psiquiatria clínica. 7ª ed., Porto Alegre: Artes Médicas, 1997, 809-946.
Cronin-Golomb A, Amick M. Spatial abilities in aging, Alzheimer’s disease, and Parkinson’s disease. In: Boller F, Cappa S (Eds.). Handbook of neuropsychology, 2nd ed., Vol. 6, Amsterdam: Elsevier, 2001, 119–43.
Sanvito WL. Síndromes neurológicas. 2a ed. São Paulo: Editora Atheneu, 1997, 382.
Amick M, Cronin-Golomb A, Gilmore G. Visual processing of rapidly presented stimuli is normalized in Parkinson’s disease when proximal stimulusstrength is enhanced. Vis Res 2003;43(26):2827–35.
Cummings JL. Depression and Parkinson disease: a review. Am J Psychiatr1992; 149:443–54.
McDonald WM, Richard IH, DeLong MR. Prevalance, etiology, and treatment of depression in Parkinson’s disease. Biol Psychiatr 2003;54:363–75.
Dooneief G, Mirabello E, Bell K, Marder K, Stern Y, Mayeux R. An estimate of the incidence of depression in idiopathic Parkinson’s disease. Arch Neurol 1992;49:305–7.
Allain H, Schuck S, Mauduit N. Depression in Parkinson’s disease. BMJ 2000;320:1287–8.
Ranoux D. Depression et maladie de Parkinson. Encephale 2000;26(3):22–6.
Schrag A, Hahanshahi M, Quinn N. How does Parkinson’s Disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 2000;6:1112–8.
Slawek J, Derejko M, Lass P. Factors affecting the quality of life of patients with idiopathic Parkinson’s disease-a cross-sectional study in outpatient clinic attendees. Park Relat Disord 2005;11(7):465–8.
Leentjens AF, Van den Akker M, Metsemakers JF, Lousberg R, Verhey FR. Higher incidence of depression preceding the onset of Parkinson’s disease: a register study. Mov Disord 2003;18(4):414–8.
Taylor AE, Saint-Cyr JA, Lang AE, Kenny FT. Parkinson’s disease and depression. A critical re-evaluation. Brain 1986;109(2):279–92.
Gotham AM, Brown RG, Marsden CD. Depression in Parkinson’s disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatr 1986;49(4):381–9.
Sandyk R. Locus coeruleus-pineal melatonin interactions and the pathogenesis of the “on–off” phenomenon associated with mood changes and sensory symptoms in Parkinson’s disease. Int J Neurosci 1989;49(12):95–101.
Kostic VS, Filipovic SR, Lecic D, Momcilovic D, Sokic D, Sternic N. Effect of age at onset on frequency of depression in Parkinson’s disease. J Neurol Neurosurg Psychiatr 1994;57(10):1265–7.
Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17(5):427-42.
Horta W. Escalas clínicas para avaliação de pacientes com doença de Parkinson. In: Meneses MS, Teive HAG. Doença de Parkinson: aspectos clínicos e cirúrgicos. Rio de Janeiro: Guanabara Koogan,1996, 83-96.
Shenkman ML, Clark K, Xie T, Kuchibhatla M, Shinberg M, Ray L. Spinal movement and performance of standing reach task in participants with and without Parkinson disease. Phys Ther 2001;81:1400-11.
Bertolucci PHF, Brucki SMD, Campacci SR, Juliano Y. O Mini-exame do estado mental em uma população geral: Impacto da escolaridade. Arq Neuropsiquiatr 1994;52:1-7.
Tombaught TN, Mcintyre NJ. The Mini-Mental State Examination: A comprehensive review. J Am Geri Soc 1992;40: 922-35.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh G. An inventory for measuring depression. Arch Gen Psychiatr 1961;4:53-63.
Meneses MS, Teive HAG. Doença de Parkinson. Rio de Janeiro: Guanabara Koogan, 2003, 372 p.
Cerqueira ATAR. Deterioração cognitiva e depressão. SABE – Saúde, Bem-estar e Envelhecimento – O Projeto SABE no município de São Paulo: uma abordagem inicial. Brasília: Organização Pan-Americana da Saúde, 2003, pp. 143-65.
Jankvic J. The extrapyramidal disorders. In: Bennett C, Plum F (eds). Cecil textbook of medicine. 20th ed, Philadelphia: Saunders,1996, 2047 p.
Bennett JC, Plum F. Cecil – tratado de medicina interna. 20a ed. Rio de Janeiro: Guanabara Koogan, 1997, 2618 p.
Dunn G, Sham P, Hand D. Statistics and the nature of depression. Psych Med 1993;23:871-89.
Limongi JCP. Conhecendo melhor a Doença de Parkinson: uma abordagem multidisciplinar com orientações práticas para o dia-a-dia. São Paulo: Plexus Editora, 2001, 164 p.
Kashmere J, Camicioli R, Martin W. Parkinsonian syndromes and differential diagnosis. Curr Opin Neurol 2002; 15 (4):461-6.
Brooks D, Doder M. Depression in Parkinson’s disease. Curr Opin Neurol 2001;14:465-70.
Silberman CD, Laks J, Rodrigues CS, Engelhardt E. A review of depression as a risk factor in Parkinson’s disease and the impact on cognition. Rev Psiquiatr 2004; 26(1):52-60.
Paulson HL, Stern BM. Clinical manifestations of Parkinson’s Disease. In: Watts RL, Koller WC. Movement disorders neurologic principles and practice. New York: MacGraw, 2004, pp. 233-46.
